COLOTECT™ 3.0
Non-invasive Test for Colorectal Cancer Screening
LITTLE OX LTD
OFFICIAL AND EXCLUSIVE
UK DISTRIBUTOR FOR COLOTECT
BOWEL CANCER
The Importance of Colorectal Cancer Screening
Colorectal cancer (CRC) is the third most common cancer and the second deadliest cancer globally, with an estimated 1.9 million new cases and 935,000 new deaths in the world in 2020.
When CRC is caught early, the 5-year relative survival rate of CRC patients can be as high as 90%.Major guidelines generally recommend early screening to men and women above the age of 50 who are at average risk for CRC.
01
2nd Biggest Cancer Deaths
It is the 2nd biggest cause of death in the UK with 16,300 deaths per year
03
Poor Uptake
The uptake of screening is poor, leading to late diagnosis and poor prognosis
02
4th Biggest Cancer
Bowel cancer is the 4th biggest cancer in the UK with 42,000 new cases per year
04
10% Survival Rate
Around 10 out of 100 people (around 10%) with stage 4 bowel cancer (also called Dukes' D) will survive their cancer for 5 years or more after they're diagnosed.
Simple Process
Customer/Physician orders test and Colotect is shipped out
.jpg)
Customer collects stool samples at home
Customer books online for collection, Fedex ships stool samples back to the processing laboratory
Laboratory conducts testing and generates report